We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
4mjh
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_4mjh| PDB=4mjh | SCENE= }} | |
| + | ===Human Hsp27 core domain in complex with C-terminal peptide=== | ||
| - | The | + | ==Disease== |
| + | [[http://www.uniprot.org/uniprot/HSPB1_HUMAN HSPB1_HUMAN]] Autosomal dominant Charcot-Marie-Tooth disease type 2F;Distal hereditary motor neuropathy type 2. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/HSPB1_HUMAN HSPB1_HUMAN]] Involved in stress resistance and actin organization. | ||
| - | + | ==About this Structure== | |
| + | [[4mjh]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MJH OCA]. | ||
| + | [[Category: Cascio, D.]] | ||
| + | [[Category: Eisenberg, D.]] | ||
| + | [[Category: Laganowsky, A.]] | ||
| + | [[Category: Sawaya, M R.]] | ||
| + | [[Category: Amyloid]] | ||
| + | [[Category: Cancer]] | ||
| + | [[Category: Chaperone]] | ||
| + | [[Category: Small heat shock protein]] | ||
Revision as of 06:44, 9 April 2014
Contents |
Human Hsp27 core domain in complex with C-terminal peptide
Disease
[HSPB1_HUMAN] Autosomal dominant Charcot-Marie-Tooth disease type 2F;Distal hereditary motor neuropathy type 2. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry.
Function
[HSPB1_HUMAN] Involved in stress resistance and actin organization.
About this Structure
4mjh is a 4 chain structure. Full crystallographic information is available from OCA.
